Charles River (CRL) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

CRL Charles River

Watchlist

165.310
+0.430+0.26%

Close Feb 28 16:00 ET

165.310
0.0000.00%

Post 20:01 ET

8.45BMarket Cap826.55P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Wall Street Today: Market Ends Wild Political TV Day in the Green
Kevin TraversFeb 28 15:38 ET
Bell Global Equities Sold Charles River Laboratories International (CRL) Due To Its Potential For On-going Risk To Earnings
Yahoo FinanceFeb 28 09:35 ET
Wall Street Today: Market Decides Down is the Direction
Kevin TraversFeb 27 16:01 ET
Live Stock News: Nvidia Does not run Things Around here Anymore
Kevin TraversFeb 27 11:06 ET
Gene Prediction Tools Market Analysis Report 2025-2030, With Bio-Techne, Charles River Laboratories, Eurofins, GenScript, Danaher, MedGenome, Sino Biological, Syngene & Twist Bioscience
Yahoo FinanceFeb 27 09:17 ET
FibroBiologics Completes Master Cell Bank for CYWC628 in Collaboration With Charles River Laboratories
Quiver QuantitativeFeb 27 08:41 ET

Comments

Smokey93

Feb 27 13:30

$FibroBiologics (FBLG.US)$
$Charles River (CRL.US)$
hidden 💎?

韭菜变主力

Jan 17 22:05

$Charles River (CRL.US)$ It’s cheap, but no sizable upside without material improvement of the earnings. 140s might be in the cards. Go against the trend is a dangerous thing. Those sitting on a loss have to cut loss given the extreme resistance above. Only improvement of the earnings can save this stock. They also seem to be losing some clients to competitors.

韭菜变主力

Dec 30, 2024 01:18

$Charles River (CRL.US)$ In this almost everything rally market with stocks doubling easily, biomedical research companies have found growth is extremely hard to come by, and P/E has been stuck going nowhere.

Moomoo AI

Feb 29, 2024 01:09

The CEOs of both Wheeler Bio and Charles River express optimism about the partnership, believing that the integration of discovery CRO and CDMO workflows will speed up the path to first-in-human trials and bring new treatments to patients faster.

Press Release: Wheeler Bio Seals Agreement With Charles River to Offer Portable CMC(R) to Discovery Clients to Accelerate Their Journey to First-in-Human Use

Moomoo AI

Feb 26, 2024 04:44

Insider's recent share sale, even below current price, suggests satisfaction with lower valuation. Despite high insider ownership, this selling hints at caution. The company also has 1 warning sign worth noting before buying shares.